This job is no longer available
Four-year PhD Studentships
As part of an on-going contribution to Scottish life sciences, MSD, a global healthcare leader, has given a substantial monetary funding to the Scottish Funding Council (SFC) for distribution via SULSA to develop and deliver a high quality drug discovery research and training programme. The fund, which is backed by additional investment from the SFC and the six SULSA Universities, is launching with a programme for 18 four-year PhD studentships, starting in October 2012. The PhDs will all be in the field of Drug Discovery and will benefit from a high-quality training programme, travel and consumables budgets, as well as being integrated into the SULSA network of excellence. All aspects of the programme have been geared towards attaining the highest value in terms of scientific discovery, training and impact.
Applications are invited from outstanding UK and EU students who hold, or expect to gain, a first or upper second-class degree or equivalent. The closing date for applications is 13th August 2012. Successful candidates will receive an annual stipend in line with RCUK rates and payment of their tuition fee. Applicants should be available for interview on selected dates still to be determined during August 2012.
Please click on the 'Apply Now' button to be redirected to our website for information on how to apply.
List of available projects:
- Professor Manfred Auer - Design, synthesis and screening of miniaturized combinatorial chemical libraries for the discovery of small molecular ligands for the human WD40 domain
- Dr Dominic Campopiano - Developing drugs from Dynamic Chemical Libraries
- Professor Ian Gilbert – Metabolomics to design novel antibacterials
- Professor Andrew Hopkins – Automating drug design
- Dr Iva Navratilova - Biophysical screening of GPCRs
- Dr Tilo Kunath - Combining stem cell technologies, in-silico design, synthesis of large scale combinatorial chemical libraries on microbeads, and high-throughput screening to find new lead compounds for Parkinson's disease.
- Dr Stuart MacNeill – Nuclear DNA polymerases in trypanosomes: target validation and drug discovery